In recent trading session, Omega Therapeutics Inc (NASDAQ:OMGA) saw 14.66 million shares changing hands at last check today with its beta currently measuring 1.62. Company’s recent per share price level of $0.19 trading at $0.04 or 23.31% at last check today assigns it a market valuation of $10.52M. That most recent trading price of OMGA’s stock is at a discount of -2247.37% from its 52-week high price of $4.46 and is indicating a premium of 47.37% from its 52-week low price of $0.10.

For Omega Therapeutics Inc (OMGA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.28 in the current quarter.

Omega Therapeutics Inc (NASDAQ:OMGA) trade information

Upright in the green today for gaining 23.31%, in the last five days OMGA remained trading in the red while hitting it’s week-highest on Friday, 02/14/25 when the stock touched $0.19 price level, adding 24.0% to its value on the day. Omega Therapeutics Inc’s shares saw a change of -74.53% in year-to-date performance and have moved -13.88% in past 5-day. Omega Therapeutics Inc (NASDAQ:OMGA) showed a performance of -60.02% in past 30-days.

Wall Street analysts have assigned a consensus price target of 9 to the stock, which implies a rise of 97.89% to its recent value today. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 11. It follows that stock’s current price would drop -3584.21% in reaching the projected high whereas dropping to the targeted low would mean a loss of -3584.21% for stock’s current value.

Omega Therapeutics Inc (OMGA) estimates and forecasts

This year revenue growth is estimated to rise 100.19% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 850k for the same. And 1 analysts are in estimates of company making revenue of 850k in the next quarter. Company posted 989k and 2.36M of sales in current and next quarters respectively a year earlier.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -48.08% during past 5 years.

Omega Therapeutics Inc (NASDAQ:OMGA)’s Major holders

FLAGSHIP PIONEERING INC. is the top institutional holder at OMGA for having 29.23 million shares of worth $60.5 million. And as of 2024-06-30, it was holding 52.9924 of the company’s outstanding shares.

The second largest institutional holder is FMR LLC, which was holding about 6.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.3181 of outstanding shares, having a total worth of $12.92 million.

On the other hand, Fidelity Growth Company Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024, the former fund manager was holding 1.97 shares of worth $0.38 million or 3.55% of the total outstanding shares. The later fund manager was in possession of 779.1 shares on Sep 30, 2024, making its stake of worth around $0.15 million in the company or a holder of 1.41% of company’s stock.